Hormone Receptor-Negative as a Predictive Factor for Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer

Einstein (São Paulo, Brazil) - Brazil
doi 10.31744/einstein_journal/2019ao3434
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein

Related search

Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

A microRNA Signature Associated With Pathological Complete Response to Novel Neoadjuvant Therapy Regimen in Triple-Negative Breast Cancer

Tumor Biology
MedicineCancer Research
2017English

Relevance of Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2016English

Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2010English

Pathologic Evaluation of Breast Cancer After Neoadjuvant Therapy

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2016English

The Nuclear Transcription Factor B/BCL-2 Pathway Correlates With Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Genome-Wide DNA Methylation Signatures to Predict Pathologic Complete Response From Combined Neoadjuvant Chemotherapy With Bevacizumab in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Predicting Successful Conservative Surgery After Neoadjuvant Chemotherapy in Hormone Receptor-Positive, HER2-Negative Breast Cancer

Journal of Breast Disease
2018English

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy